Efficient Neutralization of SARS-CoV-2 Omicron and Other VOCs by a Broad Spectrum Antibody 8G3

Hang Ma; Chien-Te K. Tseng; Huifang Zong; Yunji Liao; Yong Ke; Haoneng Tang; Lei Wang; Zhenyu Wang; Yang He; Yunsong Chang; Shusheng Wang; Aleksandra Drelich; Jason Hsu; Vivian Tat; Yunsheng Yuan; Mingyuan Wu; Junjun Liu; Yali Yue; Wenbo Xu; Hua Chen; Yanlin Bian; Baohong Zhang; Haiyang Yin; En Zhang; Xiaoxiao Zhang; John Gilly; Tao Sun; Lei Han; Yueqing Xie; Hua Jiang; Jianwei Zhu.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-482049

Documentos relacionados

  1. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
  2. Divergent Antibody Repertoires Found for Omicron versus Wuhan SARS-CoV-2 Strains Using Ig-MS.
  3. Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.
  4. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
  5. Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
  6. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
  7. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
  8. Computationally restoring the potency of a clinical antibody against Omicron.
  9. Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
  10. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.